PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Progyny, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$27.84+0.98 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $2.29B
- P/E (TTM)
- 30.3
- Dividend yield
- –
Progyny, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fertility benefits services revenue | $230.21M | $209.43M | $208.64M | $201.95M | $213.94M | $206.41M | $187.46M | $178.76M | $193.56M | $169.77M | $171.30M | $175.11M | 65.7% | +7.6% |
| Pharmacy benefits services revenue | $120.30M | $119.07M | $109.77M | $111.40M | $118.93M | $117.63M | $110.97M | $107.87M | $110.52M | $108.31M | $98.64M | $105.78M | 34.3% | +1.2% |
By region
From the segment and revenue-disaggregation notes of Progyny's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.